Cargando…
Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation
BACKGROUND: In sickle cell disease (SCD), the mitogen-activated protein kinase (MAPK) ERK1/2 is constitutively active and can be inducible by agonist-stimulation only in sickle but not in normal human red blood cells (RBCs). ERK1/2 is involved in activation of ICAM-4-mediated sickle RBC adhesion to...
Autores principales: | Soderblom, Erik J, Thompson, J Will, Schwartz, Evan A, Chiou, Edward, Dubois, Laura G, Moseley, M Arthur, Zennadi, Rahima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558407/ https://www.ncbi.nlm.nih.gov/pubmed/23286773 http://dx.doi.org/10.1186/1559-0275-10-1 |
Ejemplares similares
-
MEK Inhibitors, Novel Anti-Adhesive Molecules, Reduce Sickle Red Blood Cell Adhesion In Vitro and In Vivo, and Vasoocclusion In Vivo
por: Zennadi, Rahima
Publicado: (2014) -
MEK1/2 as a Therapeutic Target in Sickle Cell Disease
por: Zennadi, Rahima
Publicado: (2019) -
The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications
por: Wang, Qinhong, et al.
Publicado: (2021) -
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
por: Chauhan, Waseem, et al.
Publicado: (2023) -
Disrupting the vicious cycle created by NOX activation in sickle erythrocytes exposed to hypoxia/reoxygenation prevents adhesion and vasoocclusion
por: MacKinney, Anson, et al.
Publicado: (2019)